{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:52:15Z","timestamp":1792173135544,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T00:00:00Z","timestamp":1428537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00404-015-3692-3","type":"journal-article","created":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T04:52:22Z","timestamp":1428468742000},"page":"749-756","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Safety of insulin analogs during pregnancy: a meta-analysis"],"prefix":"10.1007","volume":"292","author":[{"given":"ShiShi","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiYing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,9]]},"reference":[{"key":"3692_CR1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2337\/dc07-2345","volume":"31","author":"JM Lawrence","year":"2008","unstructured":"Lawrence JM, Contreras R, Chen W et al (2008) Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially\/ethnically diverse population of pregnant women, 1999-2005. Diabetes Care 31:899\u2013904","journal-title":"Diabetes Care"},{"issue":"11","key":"3692_CR2","first-page":"E104","volume":"19","author":"CL DeSisto","year":"2014","unstructured":"DeSisto CL, Kim SY, Charma AJ (2014) Prevalence estimates of gestational diabetesmellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007\u20132010. Prev Chronic Dis 19(11):E104","journal-title":"Prev Chronic Dis"},{"key":"3692_CR3","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","volume":"358","author":"HAPO Study Cooperative Research Group, Metaqer BE, Lowe LP, et al","year":"2008","unstructured":"HAPO Study Cooperative Research Group, Metaqer BE, Lowe LP et al (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991\u20132002","journal-title":"N Engl J Med"},{"key":"3692_CR4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.4158\/EP10003.RA","volume":"16","author":"EJ Edson","year":"2010","unstructured":"Edson EJ, Bracco OL, Vambergue A et al (2010) Managing diabetes during pregnancy with insulin lispro:a safe alternative to human insulin. Endocr Pract 16:1020\u20131027","journal-title":"Endocr Pract"},{"key":"3692_CR5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00592-008-0024-0","volume":"45","author":"A Lapolla","year":"2008","unstructured":"Lapolla A, Dalfra MG, Spezia R et al (2008) Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience. Acta Diabetol 45:61\u201366","journal-title":"Acta Diabetol"},{"key":"3692_CR6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/14767050802022797","volume":"21","author":"CP Durnwald","year":"2008","unstructured":"Durnwald CP, Landon MB (2008) A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy. J Matern Fetal Neonatal Med 21:309\u2013313","journal-title":"J Matern Fetal Neonatal Med"},{"key":"3692_CR7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/pdi.1423","volume":"26","author":"M Banerjee","year":"2009","unstructured":"Banerjee M, Bhattacharya A, Hughes SM et al (2009) Efficacy of insulin lispro in pregnancies complicated with pregestational diabetes mellitus. Pract Diabetes Int 26:366\u2013370","journal-title":"Pract Diabetes Int"},{"issue":"44","key":"3692_CR8","first-page":"4","volume":"80","author":"Y Aydin","year":"2008","unstructured":"Aydin Y, Berker D, Direktor N et al (2008) Is insulin lispro safe in pregnant women: does it cause any adverse outcomes on infants or mothers? Diabetes Res Clin Pract 80(44):4\u2013448","journal-title":"Diabetes Res Clin Pract"},{"key":"3692_CR9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.medcli.2010.11.021","volume":"137","author":"M Garc\u00eda-Dom\u00ednguez","year":"2011","unstructured":"Garc\u00eda-Dom\u00ednguez M, Herranz L, Hillman N et al (2011) Use of insulin lispro during pregnancy in women with pregestational diabetes mellitus. Med Clin 137:581\u2013586","journal-title":"Med Clin"},{"key":"3692_CR10","first-page":"PI29","volume":"10","author":"K Cypryk","year":"2004","unstructured":"Cypryk K, Sobczak M, Perty\u0144ska-Marczewska M et al (2004) Pregnancy complications and perinatal outcome in diabetic women treated with Humalog (insulin lispro) or regular human insulin during pregnancy. Med Sci Monit 10:PI29\u2013PI32","journal-title":"Med Sci Monit"},{"key":"3692_CR11","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1007\/s00125-002-0958-7","volume":"45","author":"IM Evers","year":"2002","unstructured":"Evers IM, de Valk HW, Mol BW et al (2002) Macrosomia despite good glycaemic control in type1 diabetic pregnancy results of a nationalwide study in the Netherlands. Diabetologia 45:1484\u20131489","journal-title":"Diabetologia"},{"key":"3692_CR12","doi-asserted-by":"crossref","first-page":"151975","DOI":"10.1155\/2013\/151975","volume":"2013","author":"A Colatrella","year":"2013","unstructured":"Colatrella A, Visalli N, Abbruzzese S et al (2013) Comparison of insulin lispro protamine suspension with NPH insulin in pregnant women with type 2 and gestational diabetes mellitus: maternal and perinatal outcomes. Int J Endocrinol 2013:151975","journal-title":"Int J Endocrinol"},{"key":"3692_CR13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3109\/09513590.2011.650661","volume":"28","author":"V Balaji","year":"2012","unstructured":"Balaji V, Balaji MS, Alexander C et al (2012) Premixed insulin aspart 30 (BIAsp 30) versus premixed human insulin 30 (BHI 30) in gestational diabetes mellitus: a randomized open-label controlled study. Gynecol Endocrinol 28:529\u2013532","journal-title":"Gynecol Endocrinol"},{"key":"3692_CR14","first-page":"99","volume":"58","author":"V Balaji","year":"2010","unstructured":"Balaji V, Balaji MS, Alexander C et al (2010) Premixed insulin aspart 30 (Bia sp 30) vs premixed human insulin 30 (Bhi 30) in gestational diabetes mellitus\u2014a pilot study. J Assoc Physician India 58:99\u2013101","journal-title":"J Assoc Physician India"},{"key":"3692_CR15","doi-asserted-by":"crossref","first-page":"186.e1","DOI":"10.1016\/j.ajog.2007.08.005","volume":"198","author":"M Hod","year":"2008","unstructured":"Hod M, Damm P, Kaaja R et al (2008) Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol 198:186.e1\u2013186.e7","journal-title":"Am J Obstet Gynecol"},{"key":"3692_CR16","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1080\/00016340701515282","volume":"86","author":"M Poyhonen-Alho","year":"2007","unstructured":"Poyhonen-Alho M, Ronnemaa T, Saltevo J et al (2007) Use of insulin glargine during pregnancy. Acta Obstetricia et Gynecologica 86:1171\u20131174","journal-title":"Acta Obstetricia et Gynecologica"},{"key":"3692_CR17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/14767050802638170","volume":"22","author":"YM Fang","year":"2009","unstructured":"Fang YM, MacKeen D, Egan JF et al (2009) Insulin glargine compared with Neutral Protamine Hagedorn insulin in the treatment of pregnant diabetics. J Matern Fetal Neonatal Med 22:249\u2013253","journal-title":"J Matern Fetal Neonatal Med"},{"key":"3692_CR18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1055\/s-0029-1220782","volume":"26","author":"RS Egerman","year":"2009","unstructured":"Egerman RS, Ramsey RD, Kao LW et al (2009) Perinatal outcomes in pregnancies managed with antenatal insulin glargine. Am J Perinatol 26:591\u2013595","journal-title":"Am J Perinatol"},{"key":"3692_CR19","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.clinthera.2008.08.013","volume":"30","author":"MP Imbergamo","year":"2008","unstructured":"Imbergamo MP, Amato MC, Sciortino G et al (2008) use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study. Clin Ther 30:1476\u20131484","journal-title":"Clin Ther"},{"key":"3692_CR20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.diabres.2010.03.015","volume":"89","author":"CA Negrato","year":"2010","unstructured":"Negrato CA, Rafacho A, Negrato G et al (2010) Glargine vs. NPH insulin therapy in pregnancies complicated by diabetes: an observational cohort study. Diabetes Res Clin Pract 89:46\u201351","journal-title":"Diabetes Res Clin Pract"},{"key":"3692_CR21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1471-0528.2006.01216.x","volume":"114","author":"N Price","year":"2007","unstructured":"Price N, Bartlett C, Gillmer M (2007) Use of insulin glargine during pregnancy: a case\u2013control pilot study. BJOG 114:453\u2013457","journal-title":"BJOG"},{"key":"3692_CR22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-0028-1095181","volume":"26","author":"JG Smith","year":"2009","unstructured":"Smith JG, Manuck TA, White J et al (2009) Insulin glargine versus neutral protamine hagedorn insulin for treatment of diabetes in pregnancy. Am J Perinatol 26:57\u201362","journal-title":"Am J Perinatol"},{"key":"3692_CR23","first-page":"491","volume":"34","author":"MP Imbergamo","year":"2012","unstructured":"Imbergamo MP, Amato MC, Amodeo R et al (2012) Use of basal insulin analog detemir in pregnant women with type1 diabetes:a case-control retrospective study. Giorn Ital Ostet Ginecol 34:491\u2013498","journal-title":"Giorn Ital Ostet Ginecol"},{"key":"3692_CR24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/14767058.2013.799650","volume":"27","author":"M Hod","year":"2014","unstructured":"Hod M, Mathiesen ER, Jovanovic L et al (2014) A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes. J Matern Fetal Neonatal Med 27:7\u201313","journal-title":"J Matern Fetal Neonatal Med"},{"key":"3692_CR25","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.4158\/EP10003.RA","volume":"16","author":"EJ Edson","year":"2010","unstructured":"Edson EJ, Bracco OL, Vambergue A et al (2010) Managing diabetes during pregnancy with insulin lispro :a safe alternative to human insulin. Endocr Pract 16:1020\u20131027","journal-title":"Endocr Pract"},{"key":"3692_CR26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1089\/dia.2011.0032","volume":"13","author":"CG Blanco","year":"2011","unstructured":"Blanco CG, Ballesteros AC, Saladich IG et al (2011) Glycemic control and pregnancy outcomes in women with type 1 Diabetes mellitus using lispro versus regular insulin: a systematic review and meta-analysis. Diabetes Technol Ther 13:907\u2013911","journal-title":"Diabetes Technol Ther"},{"key":"3692_CR27","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/aogs.12192","volume":"92","author":"AS Elhddad","year":"2013","unstructured":"Elhddad AS, Lashen H (2013) Fetal growthin relation tomaternal and fetal IGF-axes: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 92:997\u20131006","journal-title":"Acta Obstet Gynecol Scand"},{"key":"3692_CR28","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2337\/diabetes.49.6.999","volume":"49","author":"P Kurtzhals","year":"2000","unstructured":"Kurtzhals P, Sch\u00e4ffer L, S\u00f8rensen A et al (2000) Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 49:999\u20131005","journal-title":"Diabetes"},{"key":"3692_CR29","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00003495-199754040-00006","volume":"54","author":"MI Wilde","year":"1997","unstructured":"Wilde MI (1997) Mc Tavish D. Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus. Drugs 54:597\u2013614","journal-title":"Drugs"},{"key":"3692_CR30","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.2337\/diacare.26.5.1390","volume":"26","author":"R Boskovic","year":"2003","unstructured":"Boskovic R, Knie B, Feig DS et al (2003) Transfer of insulin lispro across the human placenta. Diabetes Care 26:1390\u20131394","journal-title":"Diabetes Care"},{"key":"3692_CR31","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/bmj.39505.641273.AD","volume":"336","author":"The Guideline Development Group","year":"2008","unstructured":"The Guideline Development Group (2008) Management of diabetes from preconception to the postnatal period: summary of NICE guidance. BMJ 336:714\u2013717","journal-title":"BMJ"},{"key":"3692_CR32","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1210\/jc.2013-2465","volume":"98","author":"I Blumer","year":"2013","unstructured":"Blumer I, Hadar E, Hadden DR et al (2013) Diabetes and Pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 98:4227\u20134249","journal-title":"J Clin Endocrinol Metab"},{"key":"3692_CR33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1345\/aph.1P327","volume":"45","author":"E Pollex","year":"2011","unstructured":"Pollex E, Moretti ME, Koren G et al (2011) Safety of Insulin glargine use in pregnancy: a systematic review and meta-analysis. Ann Pharmacother 45:9\u201316","journal-title":"Ann Pharmacother"},{"key":"3692_CR34","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s00125-010-1760-6","volume":"53","author":"L Sciacca","year":"2010","unstructured":"Sciacca L, Cassarino MF, Genua M et al (2010) Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling. Diabetologia 53:1743\u20131753","journal-title":"Diabetologia"},{"key":"3692_CR35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2337\/dc09-1045","volume":"33","author":"EK Pollex","year":"2010","unstructured":"Pollex EK, Feig DS, Lubetsky A et al (2010) Insulin glargine safety in pregnancy: a transplacental transfer study. Diabetes Care 33:29\u201333","journal-title":"Diabetes Care"},{"key":"3692_CR36","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3109\/14767058.2012.743523","volume":"26","author":"NF Callesen","year":"2013","unstructured":"Callesen NF, Damm J, Mathiesen JM et al (2013) Treatment with the long-acting insulin analogues detemir or glargine during pregnancy in women with type 1 diabetes:comparison of glycaemic control and pregnancy outcome. J Mater Fetal Neonatal Med 26:588\u2013592","journal-title":"J Mater Fetal Neonatal Med"},{"key":"3692_CR37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2393-14-96","volume":"14","author":"K Shankardass","year":"2014","unstructured":"Shankardass K, O\u2019campo P, Dodds L et al (2014) Magnitude of income- related disparities in adverse perinatal outcomes. BMC Pregnancy Childbith 14:96","journal-title":"BMC Pregnancy Childbith"},{"key":"3692_CR38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.amepre.2010.05.012","volume":"39","author":"P Blumenshine","year":"2010","unstructured":"Blumenshine P, Egerter S, Barclay CJ et al (2010) Socioeconomic disparities in adverse birth outcomes: a systematic review. Am J Prev Med 39:263\u2013272","journal-title":"Am J Prev Med"},{"key":"3692_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.socscimed.2012.08.021","volume":"76","author":"LH Mortense","year":"2013","unstructured":"Mortense LH (2013) Socioeconomic inequality in birth weight and gestational age in Denmark 1996-2007: using a family-based approach to explore alternative explanations. Soc Sci Med 76:1\u20137","journal-title":"Soc Sci Med"},{"key":"3692_CR40","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/AOG.0000000000000271","volume":"123","author":"CM Scifres","year":"2014","unstructured":"Scifres CM, Feqhali MN, Althouse AD et al (2014) Effect of excess gestational weight gain on pregnancy outcomes in women with type1 diabetes. Obstet Gynecol 123:1295\u20131302","journal-title":"Obstet Gynecol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-015-3692-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-015-3692-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-015-3692-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T02:54:45Z","timestamp":1566528885000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-015-3692-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,9]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["3692"],"URL":"https:\/\/doi.org\/10.1007\/s00404-015-3692-3","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,9]]}}}